Note: The contents of this blog are for informational purposes only and should not be construed as medical advice or substitute for professional care. For medical emergencies, dial 911!
Liver cancer patients see treatment from kidney cancer drug
Posted Jun 5th 2007 1:50PM by Brian White
Filed under: Drug, All Cancers
Liver cancer is one of the toughest cancers to battle, and it claims close to half a million people each year as sufferers. Some positive news on the liver cancer front was discovered recently, as cancer specialists said that the drug sorafenib was seen to
give liver cancer patients long lifespans compared to study participants who took dummy pills at the same time. The survival rates were 10.7 months and 8 months, respectively.
What does this say? Well, there is more hope for liver cancer sufferers than before, although this study did not have what many would consider to be earth-shattering results. The big news here is that this is the first time something (anything) has been seen to give liver cancer patients any kind of survival advantage. That, in itself, is very good news.
Tags: anti-cancer drugs, Anti-cancerDrugs, cancer drugs, CancerDrugs
(Page 1)
Please keep your comments relevant to this blog entry. Email addresses are never displayed, but they are required to confirm your comments.
When you enter your name and email address, you'll be sent a link to confirm your comment, and a password. To leave another comment, just use that password.
To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br> tags.
1. The eighty extra days is for the group in the study, not the "individual" patients treated in the real world. One person may live two days, another two-hundred additional days. What may work in some patients, may not work in other patients. If the "targeted" drug either won't "get in" in the first place or if it gets pumped out/extruded or if it gets immediately metabolized inside the cell, it just isn't going to work. If a drug works extremely well for a certain percentage of cancer patients, identify which ones. If one drug or another is working for some people (not average populations) then obviously there are others out there who would also benefit.
Posted at 5:20PM on Jun 5th 2007 by Gregory D. Pawelski